Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

539.17 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Earnings Scheduled For April 26, 2023
Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion. 
Via Benzinga
Thermo Fisher Scientific Reports First Quarter 2023 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
2 Steady Stocks to Buy and Hold Forever
These two companies stand the test of time and can likely make their investors richer, too. 
Via The Motley Fool
$1000 Invested In Thermo Fisher Scientific 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity
 
Via Benzinga
9 Analysts Have This to Say About Thermo Fisher Scientific
 
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity
 
Via Benzinga
Bear Market Champions: 2 Resilient Stocks to Weather Any Storm
In uncertain times, resilient businesses can still thrive. 
Via The Motley Fool
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech ETF (NYSE: XBI), which is trading in a tight range < 
Via Benzinga
Thermo Fisher Stock Sets Up In Healthy Base; Earnings Due
Thermo Fisher stock is among the top 3 in the Medical-Research Equipment/Services industry group. It got a key rating upgrade Tuesday. 
Via Investor's Business Daily
Thermo Fisher Scientific to Host Investor Day
From Thermo Fisher Scientific Inc.
Via Business Wire
AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she is sticking with AbbVie Inc. (NYSE: ABBV), which has a 7.3% free cash flow yiel 
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity
 
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 5 Years
 
Via Benzinga
$1000 Invested In Thermo Fisher Scientific 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies
From Thermo Fisher Scientific Inc.
Via Business Wire
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From ASLAN PHARMACEUTICALS LIMITED
Via GlobeNewswire
Insiders Selling American Airlines, Costco Wholesale And 2 Other Stocks
The Nasdaq Composite closed slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
 
Via Benzinga
3 Dividend Stocks Raising Their Payouts by 10% or More This Year
Can you count on these distributions to continue rising? 
Via The Motley Fool
Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Scientific Increases Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
Got $5,000? These 2 Low-Risk Growth Stocks Also Pay Dividends
These stocks would have more than doubled your money in the past five years. 
Via The Motley Fool
3 Large-Cap Biotech Stocks to Hold for the Long Haul
These three large-cap biotech stocks survived or went up in 2022 when most of the market went down by double digits. 
Via InvestorPlace
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending." 
Via Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Is Thermo Fisher Scientific Stock a Buy Now?
Now that China's concluded its zero-COVID policy, Thermo Fisher Scientific expects rapid growth in its second-largest end market. 
Via The Motley Fool
Thermo Fisher Scientific To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
Keefe, Bruyette & Woods boosted the price target for Evercore Inc. (NYSE: EVR) from $132.5 to $137. Keefe, Bruyette & Woods analyst Matthew Moon maintained an Outperform rating. Evercore shares rose 1%... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS